SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053964
Filing Date
2024-05-07
Accepted
2024-05-07 08:05:35
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrtx-20240331.htm   iXBRL 10-Q 1169991
2 EX-10.1 hrtx-ex10_1.htm EX-10.1 206048
3 EX-31.1 hrtx-ex31_1.htm EX-31.1 15131
4 EX-31.2 hrtx-ex31_2.htm EX-31.2 14938
5 EX-32.1 hrtx-ex32_1.htm EX-32.1 16456
  Complete submission text file 0000950170-24-053964.txt   6330307

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20240331.xsd EX-101.SCH 909126
64 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20240331_htm.xml XML 1129816
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 24919713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)